SA
NUVB icon

Sanctuary Advisors’s Nuvation Bio NUVB Stock Holding History

Sanctuary Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.4K Sell
16,613
-16,895
-50% -$82.6K ﹤0.01% 2724
2026
Q1 		$144K Buy
33,508
+18,351
+121% +$102K ﹤0.01% 2418
2025
Q4 		$136K Buy
15,157
+914
+6% +$5.66K ﹤0.01% 2326
2025
Q3 		$52.7K Buy
14,243
+3,152
+28% +$8.59K ﹤0.01% 2381
2025
Q2 		$21.6K Buy
+11,091
New +$23.1K ﹤0.01% 2331

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Sanctuary Advisors's NUVB Position: Q2 2026 in Review

Sanctuary Advisors reduced its Nuvation Bio (NUVB) stake by 50% in Q2 2026, selling an estimated $82.6K and leaving 16,613 shares worth $94.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2724.

Sanctuary Advisors first reported a position in NUVB in Q2 2025 and has held it in 5 quarters since. The position peaked at $144K in Q1 2026. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Sanctuary Advisors held 16,613 shares of Nuvation Bio worth $94.4K as of Q2 2026.
  • Sanctuary Advisors sold 16,895 Nuvation Bio shares in Q2 2026, an estimated $82.6K.
  • Nuvation Bio made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #2724 holding.
  • Sanctuary Advisors first reported a position in Nuvation Bio in Q2 2025 and has held it in 5 quarters since.
  • Sanctuary Advisors's Nuvation Bio position peaked at $144K in Q1 2026.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.